Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1992 Nov;55(11):1018–1023. doi: 10.1136/jnnp.55.11.1018

Reduced regional cerebral blood flow in Huntington's disease studied by SPECT.

S G Hasselbalch 1, G Oberg 1, S A Sørensen 1, A R Andersen 1, G Waldemar 1, J F Schmidt 1, K Fenger 1, O B Paulson 1
PMCID: PMC1015285  PMID: 1469396

Abstract

Regional cerebral blood flow (rCBF) was studied in 18 patients with Huntington's disease (HD) and 19 age- and sex-matched controls with high resolution single photon emission computerised tomography (SPECT), using Tc-99m-HMPAO. Significant reductions in tracer uptake were found in the caudate and lentiform nuclei (20 and 8%) and in the cerebral cortex, especially in the frontal and parietal areas (11-13%). No significant reductions were found in the thalamus, mesial temporal cortex, and occipital cortex. Fourteen patients had neuropsychological testing. Relationship between rCBF and cognitive function was tested by regression analysis. A linear relationship was found between test scores of Wisconsin Card Sorting Test, Picture Arrangement Test and blood flow in the caudate nucleus. Other tests of cognitive function (Block Design Test, Face and Word Recognition Test, Street Fragmented Pictures Test, and Similarities Test) correlated better with flow in the cortical regions believed to be involved in solving those particular tests. These findings indicate, that blood flow is reduced in both cortical and subcortical structures in symptomatic HD, and that both reductions in cortical and subcortical blood flow may be related to cognitive function in HD.

Full text

PDF
1018

Images in this article

1020Image
on p.1020

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bamford K. A., Caine E. D., Kido D. K., Plassche W. M., Shoulson I. Clinical-pathologic correlation in Huntington's disease: a neuropsychological and computed tomography study. Neurology. 1989 Jun;39(6):796–801. doi: 10.1212/wnl.39.6.796. [DOI] [PubMed] [Google Scholar]
  2. Beal M. F., Swartz K. J., Finn S. F., Bird E. D., Martin J. B. Amino acid and neuropeptide neurotransmitters in Huntington's disease cerebellum. Brain Res. 1988 Jun 28;454(1-2):393–396. doi: 10.1016/0006-8993(88)90844-x. [DOI] [PubMed] [Google Scholar]
  3. Berent S., Giordani B., Lehtinen S., Markel D., Penney J. B., Buchtel H. A., Starosta-Rubinstein S., Hichwa R., Young A. B. Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function. Ann Neurol. 1988 Jun;23(6):541–546. doi: 10.1002/ana.410230603. [DOI] [PubMed] [Google Scholar]
  4. Conneally P. M. Huntington disease: genetics and epidemiology. Am J Hum Genet. 1984 May;36(3):506–526. [PMC free article] [PubMed] [Google Scholar]
  5. Gade A., Mortensen E. L., Bruhn P. "Chronic painter's syndrome". A reanalysis of psychological test data in a group of diagnosed cases, based on comparisons with matched controls. Acta Neurol Scand. 1988 Apr;77(4):293–306. doi: 10.1111/j.1600-0404.1988.tb05913.x. [DOI] [PubMed] [Google Scholar]
  6. Gusella J. F., Wexler N. S., Conneally P. M., Naylor S. L., Anderson M. A., Tanzi R. E., Watkins P. C., Ottina K., Wallace M. R., Sakaguchi A. Y. A polymorphic DNA marker genetically linked to Huntington's disease. Nature. 1983 Nov 17;306(5940):234–238. doi: 10.1038/306234a0. [DOI] [PubMed] [Google Scholar]
  7. Hayden M. R., Martin W. R., Stoessl A. J., Clark C., Hollenberg S., Adam M. J., Ammann W., Harrop R., Rogers J., Ruth T. Positron emission tomography in the early diagnosis of Huntington's disease. Neurology. 1986 Jul;36(7):888–894. doi: 10.1212/wnl.36.7.888. [DOI] [PubMed] [Google Scholar]
  8. Jeste D. V., Barban L., Parisi J. Reduced Purkinje cell density in Huntington's disease. Exp Neurol. 1984 Jul;85(1):78–86. doi: 10.1016/0014-4886(84)90162-6. [DOI] [PubMed] [Google Scholar]
  9. Kuhl D. E., Phelps M. E., Markham C. H., Metter E. J., Riege W. H., Winter J. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann Neurol. 1982 Nov;12(5):425–434. doi: 10.1002/ana.410120504. [DOI] [PubMed] [Google Scholar]
  10. Kuwert T., Lange H. W., Langen K. J., Herzog H., Aulich A., Feinendegen L. E. Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain. 1990 Oct;113(Pt 5):1405–1423. doi: 10.1093/brain/113.5.1405. [DOI] [PubMed] [Google Scholar]
  11. Shoulson I. Huntington disease: functional capacities in patients treated with neuroleptic and antidepressant drugs. Neurology. 1981 Oct;31(10):1333–1335. doi: 10.1212/wnl.31.10.1333. [DOI] [PubMed] [Google Scholar]
  12. Simmons J. T., Pastakia B., Chase T. N., Shults C. W. Magnetic resonance imaging in Huntington disease. AJNR Am J Neuroradiol. 1986 Jan-Feb;7(1):25–28. [PMC free article] [PubMed] [Google Scholar]
  13. Starkstein S. E., Folstein S. E., Brandt J., Pearlson G. D., McDonnell A., Folstein M. Brain atrophy in Huntington's disease. A CT-scan study. Neuroradiology. 1989;31(2):156–159. doi: 10.1007/BF00698845. [DOI] [PubMed] [Google Scholar]
  14. Stober T., Wussow W., Schimrigk K. Bicaudate diameter--the most specific and simple CT parameter in the diagnosis of Huntington's disease. Neuroradiology. 1984;26(1):25–28. doi: 10.1007/BF00328198. [DOI] [PubMed] [Google Scholar]
  15. Stokely E. M., Sveinsdottir E., Lassen N. A., Rommer P. A single photon dynamic computer assisted tomograph (DCAT) for imaging brain function in multiple cross sections. J Comput Assist Tomogr. 1980 Apr;4(2):230–240. doi: 10.1097/00004728-198004000-00022. [DOI] [PubMed] [Google Scholar]
  16. Vonsattel J. P., Myers R. H., Stevens T. J., Ferrante R. J., Bird E. D., Richardson E. P., Jr Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol. 1985 Nov;44(6):559–577. doi: 10.1097/00005072-198511000-00003. [DOI] [PubMed] [Google Scholar]
  17. Waldemar G., Hasselbalch S. G., Andersen A. R., Delecluse F., Petersen P., Johnsen A., Paulson O. B. 99mTc-d,l-HMPAO and SPECT of the brain in normal aging. J Cereb Blood Flow Metab. 1991 May;11(3):508–521. doi: 10.1038/jcbfm.1991.95. [DOI] [PubMed] [Google Scholar]
  18. Weinberger D. R., Berman K. F., Iadarola M., Driesen N., Zec R. F. Prefrontal cortical blood flow and cognitive function in Huntington's disease. J Neurol Neurosurg Psychiatry. 1988 Jan;51(1):94–104. doi: 10.1136/jnnp.51.1.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Young A. B., Penney J. B., Starosta-Rubinstein S., Markel D. S., Berent S., Giordani B., Ehrenkaufer R., Jewett D., Hichwa R. PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline. Ann Neurol. 1986 Sep;20(3):296–303. doi: 10.1002/ana.410200305. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES